Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.4c11820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Atin Chatterjee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Moh…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Microtubules, Ruthenium, Antineoplastic Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Indian Council of Medical Research, Universiteit Hasselt, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur 741246, West Bengal, India.
- Institute for Materials Research (Imo-imomec), Nanobiophysics and Soft Matter Interfaces (NSI) Group, Hasselt University, Martelarenlaan 42, B-3500 Hasselt, Belgium.
- Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, West Bengal, India.
- Technical Research Centre, S. N. Bose National Centre for Basic Sciences, Salt Lake, Kolkata 700106, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur 741246, West Bengal, India.
- Imec, Imo-imomec, Hasselt University, Wetenschapspark 1, B-3590 Diepenbeek, Belgium.
ORCID-Profile: Uttam Pal, Anitha Ethirajan, Benu Brata Das, Amitava Das
Förderung
- Indian Council of Medical Research
- Universiteit Hasselt
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
- Board of Research in Nuclear Sciences
- Ministry of Education, India
Zitieren
APA
Chatterjee, A., Sarkar, S., Bhattacharjee, S., Bhattacharyya, A., Barman, S., Pal, U., Pandey, R., Ethirajan, A., Jana, B., Das, B. B., & Das, A. (2025). Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c11820
Vancouver
Chatterjee A, Sarkar S, Bhattacharjee S, Bhattacharyya A, Barman S, Pal U, et al. Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c11820
BibTeX
@article{Chatterjee2025,
author = {Chatterjee, Atin and Sarkar, Sandip and Bhattacharjee, Sangheeta and Bhattacharyya, Arpan and Barman, Surajit and Pal, Uttam and Pandey, Raviranjan and Ethirajan, Anitha and Jana, Batakrishna and Das, Benu Brata and Das, Amitava},
title = {Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.4c11820}
}
EUVIMED